Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Bax and Bid, two proapoptotic Bcl-2 family members, inhibit homologous recombination, independently of apoptosis regulation

Abstract

In order to analyse the relationships between regulation of apoptosis and homologous recombination (HR), we overexpressed proapoptotic Bax or only-BH3 Bid proteins or antiapoptotic Bcl-2 or Bcl-XL, in hamster CHO cells or in SV40-transformed human fibroblasts. We measured HR induced by γ-rays, UVC or a specific double-strand cleavage targeted in the recombination substrate by the meganuclease I-SceI. We show here that the induction of both recombinant cells and recombinant colonies was impaired when expressing Bcl-2 family members, in hamster as well as in human cells. Moreover, the pro- as well as antiapoptotic Bcl-2 family members inhibited HR, independently of degradation of the RAD51 recombination protein and of their impact on apoptosis. These data reveal a mechanism of HR downregulation by potentially proapoptotic proteins, distinct from and parallel to degradation of recombination proteins, a situation that should also optimize the efficiency of programmed cell death.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Ausubel F, Brent R, Kingston R, Moore D, Seidman J, Smith J et al. (1999). Current Protocols in Molecular Biology. John Wiley & Sons, Inc.: Boston.

    Google Scholar 

  • Butow RA, Avadhani NG . (2004). Mol Cell 14: 1–15.

  • Cherbonnel-Lasserre C, Gauny S, Kronenberg A . (1996). Oncogene 13: 1489–1497.

  • Cho S, O’Connor SL, McDonnell TJ . (2002). Exp Cell Res 278: 158–165.

  • Delsite RL, Rasmussen LJ, Rasmussen AK, Kalen A, Goswami PC, Singh KK . (2003). Mutagenesis 18: 497–503.

  • Flygare J, Armstrong RC, Wennborg A, Orsan S, Hellgren D . (1998). FEBS Lett 427: 247–251.

  • Friedberg EC, Walker GC, Siede W . (1995). DNA Repair. ASM Press: Washington, DC.

    Google Scholar 

  • Goping IS, Gross A, Lavoie JN, Nguyen M, Jemmerson R, Roth K et al. (1998). J Cell Biol 143: 207–215.

  • Han Z, Malik N, Carter T, Reeves WH, Wyche JH, Hendrickson EA . (1996). J Biol Chem 271: 25035–25040.

  • Heimlich G, McKinnon AD, Bernardo K, Brdiczka D, Reed JC, Kain R et al. (2004). Biochem J 378: 247–255.

  • Huang DC, O'Reilly LA, Strasser A, Cory S . (1997). EMBO J 16: 4628–4638.

  • Huang Y, Nakada S, Ishiko T, Utsugisawa T, Datta R, Kharbanda S et al. (1999). Mol Cell Biol 19: 2986–2997.

  • Kamer I, Sarig R, Zaltsman Y, Niv H, Oberkovitz G, Regev L et al. (2005). Cell 122: 593–603.

  • Kaufmann T, Schlipf S, Sanz J, Neubert K, Stein R, Borner C . (2003). J Cell Biol 160: 53–64.

  • Kitao H, Yuan ZM . (2002). J Biol Chem 277: 48944–48948.

  • Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC . (1993). Cancer Res 53: 4701–4714.

  • Kuo ML, Shiah SG, Wang CJ, Chuang SE . (1999). Mol Pharmacol 55: 894–901.

  • Lambert S, Lopez BS . (2000). EMBO J 19: 3090–3099.

  • Lambert S, Lopez BS . (2002). Oncogene 21: 4065–4069.

  • Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC . (1994). Nature 371: 346–347.

  • Liang F, Han M, Romanienko PJ, Jasin M . (1998). Proc Natl Acad Sci USA 95: 5172–5177.

  • Liu Y, Naumovski L, Hanawalt P . (1997). Cancer Res 57: 1650–1653.

  • MacLachlan TK, Dash BC, Dicker DT, El-Deiry WS . (2000). J Biol Chem 275: 31869–31875.

  • Meyn MS . (1993). Science 260: 1327–1330.

  • Moynahan ME, Chiu JW, Koller BH, Jasin M . (1999). Mol Cell 4: 511–518.

  • Pierce AJ, Johnson RD, Thompson LH, Jasin M . (1999). Genes Dev 13: 2633–2638.

  • Priault M, Cartron PF, Camougrand N, Antonsson B, Vallette FM, Manon S . (2003). Cell Death Differ 10: 1068–1077.

  • Radman M . (1975). Basic Life Sci 5A: 355–367.

  • Saintigny Y, Dumay A, Lambert S, Lopez BS . (2001). EMBO J 20: 2596–2607.

  • Saintigny Y, Makienko K, Swanson C, Emond MJ, Monnat Jr RJ . (2002). Mol Cell Biol 22: 6971–6978.

  • Saintigny Y, Rouillard D, Chaput B, Soussi T, Lopez BS . (1999). Oncogene 18: 3553–3563.

  • Sambrook J, Fritsch EF, Maniatis T . (1989). Molecular Cloning. 2nd edn. Cold Spring Harbor Laboratory Press: Cold Spring Harbor.

    Google Scholar 

  • Slupianek A, Schmutte C, Tombline G, Nieborowska-Skorska M, Hoser G, Nowicki MO et al. (2001). Mol Cell 8: 795–806.

  • Smith GC, d’Adda di Fagagna F, Lakin ND, Jackson SP . (1999). Mol Cell Biol 19: 6076–6084.

  • Song Q, Lees-Miller SP, Kumar S, Zhang Z, Chan DW, Smith GC et al. (1996). EMBO J 15: 3238–3246.

  • Suzuki M, Youle RJ, Tjandra N . (2000). Cell 103: 645–654.

  • Tremblais K, Oliver L, Juin P, Le Cabellec TM, Meflah K, Vallette FM . (1999). Biochem Biophys Res Commun 260: 582–591.

  • Wiese C, Pierce AJ, Gauny SS, Jasin M, Kronenberg A . (2002). Cancer Res 62: 1279–1283.

  • Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, Youle RJ . (1997). J Cell Biol 139: 1281–1292.

  • Yin XM, Oltvai ZN, Korsmeyer SJ . (1994). Nature 369: 321–323.

  • Youn CK, Cho HJ, Kim SH, Kim HB, Kim MH, Chang IY et al. (2005). Nat Cell Biol 7: 137–147.

  • Yuan SS, Chang HL, Lee EY . (2003). Mutat Res 525: 85–92.

  • Yuan ZM, Huang Y, Ishiko T, Nakada S, Utsugisawa T, Kharbanda S et al. (1998). J Biol Chem 273: 3799–3802.

  • Zha J, Weiler S, Oh KJ, Wei MC, Korsmeyer SJ . (2000). Science 290: 1761–1765.

  • Zinkel SS, Hurov KE, Ong C, Abtahi FM, Gross A, Korsmeyer SJ . (2005). Cell 122: 579–591.

Download references

Acknowledgements

We thank Drs J Adams and S Cory for providing us the Y28ABcl-2 expression vector, Dr SJ Korsmeyer for the G145ABcl-2 mutant expression, Dr S Desagher for the Bid expression vector, Dr E May for the Bax expression vector, Dr M Jasin for the DRA10 cell line and the pDR-GFP plasmid, Dr R Monat for GM639 cell line and Dr D Marsh for critical reading of the manuscript. AD was supported by a fellowship from INSTN/EDF and then by Ministère de l’Education Nationale; CL is supported by a fellowship from INSTN. This work was supported by La Ligue Nationale contre le Cancer ‘Equipe labéllisée, La Ligue 2005’.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B S Lopez.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dumay, A., Laulier, C., Bertrand, P. et al. Bax and Bid, two proapoptotic Bcl-2 family members, inhibit homologous recombination, independently of apoptosis regulation. Oncogene 25, 3196–3205 (2006). https://doi.org/10.1038/sj.onc.1209344

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209344

Keywords

This article is cited by

Search

Quick links